LFSC F/m Emerald Life Sciences Innovation ETF

Share ▾
Share on XDownload as PDF
$45.66
+3.3% · 1 day, price
IQ’s readingComputed nightly from ETFIQ data. Not written live.

Over the year to Nov 4, 2026, LFSC returned 43.6%, against 14.8% for IWV.

Holds 38 stocks in broad innovation and megatrends, 0% of its weight in S&P 500 companiesF/m ↗Expense ratio 0.54%Fund assets $126m net assets, latest filing (Aug 31, 2026)First traded Oct 31, 2024Benchmark Russell 3000 Total Return, measured by IWV, which tracks the same indexSEC filings ↗Every F/m fund ETFIQ covers

Promise check: Not measuredETFIQ has not yet listed which companies belong to the broad innovation and megatrends theme.

LFSC risk and return scorecard

vs IWV · Nov 2024 to Oct 2026 · 103 weekly returns · dividend-adjusted

Short history · 24 months
LFSC +61.4%, IWV +27.8%, Nov 2024 to Oct 2026, distributions reinvested.
Return
MeasureLFSCIWVEdge
Total return+61.4%+27.8%LFSC
Annualized+27.3%+13.2%LFSC
Price return+61.4%+25.2%LFSC
Risk
MeasureLFSCIWVEdge
Volatility26.7%14.7%IWV
Max drawdown−24.4%−17.3%IWV
Upside capture127.3%100.0%LFSC
Downside capture91.1%100.0%LFSC (slight)
Risk-adjusted
MeasureLFSCIWVEdge
Sharpe ratio0.890.64LFSC
Sortino ratio1.360.95LFSC
Alpha vs IWV
MeasureLFSCIWVEdge
Alpha, a year+13.4%Not significant
Alpha t-stat0.88
Beta to IWV1.091.00Higher beta

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records; risk-free rate: U.S. Treasury, Daily Treasury Bill Rates, 13-week coupon equivalent Method · Data

Money in and out

Net fund flows · Aug 31, 2026
12 months to Aug 31, 2026
+$16.2m
Since Oct 2024
+$23.9m

What you earned

LFSC +3.9%, IWV −0.8%: total return over one month to Nov 4, 2026.
LFSC+3.9%
IWV−0.8%
LFSC −3.8%, IWV −0.3%: total return over three months to Nov 4, 2026.
LFSC−3.8%
IWV−0.3%
LFSC +16.9%, IWV +4.9%: total return over six months to Nov 4, 2026.
LFSC+16.9%
IWV+4.9%
LFSC +24.7%, IWV +13.3%: total return over the year to Nov 4, 2026.
LFSC+24.7%
IWV+13.3%
LFSC +43.6%, IWV +14.8%: total return over one year to Nov 4, 2026.
LFSC+43.6%
IWV+14.8%
LFSC +83.4%, IWV +37.0%: total return since launch to Nov 4, 2026.
LFSC+83.4%
IWV+37.0%

What did you actually buy?

Broad innovation and megatrends · holdings as of Aug 31, 2026
0.0%
Already in the S&P 500
100.0%
Active share vs the S&P 500
54.0%
Top ten holdings
+43.6%
Total return, 1 year
Share already in the S&P 500
0.0% of the fund by weight, holdings as of Aug 31, 2026.
Ten largest holdings
Travere Therapeutics Inc8.7%
Corcept Therapeutics Inc6.7%
Spyre Therapeutics Inc6.7%
LivaNova PLC6.6%
Cogent Biosciences Inc6.5%
Mirum Pharmaceuticals Inc4.3%
Billiontoone Inc3.9%
Guardant Health Inc3.8%
Cytokinetics Inc3.5%
United Therapeutics Corp3.3%

More on LFSC

Every number below is on this page. Open what you need.

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Price, 1 year

$45.66+3.3%1 day, priceClose, Nov 4, 2026

Price only. No distribution was paid over these days, so total return is the same. Computed by ETFIQ from Tiingo daily prices.

Source: Tiingo end-of-day prices. Data as of Nov 4, 2026. Updated every trading night. Report a data error

Points (pts) are percentage points.

LFSC returns by window: total return, cash paid and price change
WindowTotal returnBenchmark (IWV)Gap to IWVS&P 500 (SPY)
1M Oct 5 – Nov 4, 2026+3.9%−0.8%+4.7 pts−1.0%
3M Aug 5 – Nov 4, 2026−3.8%−0.3%−3.5 pts−0.1%
6M May 6 – Nov 4, 2026+16.9%+4.9%+12.0 pts+5.0%
YTD Dec 31, 2025 – Nov 4, 2026+24.7%+13.3%+11.4 pts+13.3%
1Y Nov 4, 2025 – Nov 4, 2026+43.6%+14.8%+28.8 pts+14.8%
Since launch Oct 31, 2024 – Nov 4, 2026+83.4%+37.0%+46.4 pts+38.0%
Since launch, annualised Oct 31, 2024 – Nov 4, 2026+35.2%–––

Total returns, distributions reinvested. Listed Oct 2024: no 3 years windows.

Source: Tiingo end-of-day prices, with distributions reinvested.

Money in and out

Monthly data · as of Aug 31, 2026

LFSC: in the month to Aug 31, 2026, net $895k came in, by its SEC filing.

12 months
+$16.2m
25.0% of $64.6m on Aug 31, 2025
Sep 1, 2025 to Aug 31, 2026
monthly, from SEC filings
Since Oct 2024
+$23.9m
Oct 1, 2024 to Aug 31, 2026
monthly, from SEC filings

Computed by ETFIQ from the monthly sales and redemptions LFSC files with the SEC on Form N-PORT.

How this is computed

ETFIQ reads no daily data for this fund, so its flows are monthly, and the latest month filed is Aug 2026. Every day and month ETFIQ holds for LFSC, back to Oct 2024, is in its flows file. Flows across every fund · How these flows are computed · Compare LFSC with other funds in the flows tool

Month by month, money in and money outOct 2024 to Aug 2026

LFSC, money in and money out each month from Oct 2024 to Aug 2026: two bars a month, money in above the line and money out below. Every bar is from LFSC’s SEC filings (N-PORT item B.6). Of the 23 months listed, money came in on net in 19 and went out in 3.

Every bar is from LFSC’s SEC filings (N-PORT item B.6). Of the 23 months listed, money came in on net in 19 and went out in 3.

MonthInOutNet
Aug 2026 SEC Form N-PORT+$3.8m−$2.9m+$895k
Jul 2026 SEC Form N-PORT+$2.3m−$457k+$1.8m
Jun 2026 SEC Form N-PORT+$1.2m$0+$1.2m
May 2026 SEC Form N-PORT+$9.2m−$9.3m−$129k
Apr 2026 SEC Form N-PORT+$4.2m−$4.2m−$18k
Mar 2026 SEC Form N-PORT+$8.5m−$7.2m+$1.3m
Feb 2026 SEC Form N-PORT+$9.4m−$5.1m+$4.3m
Jan 2026 SEC Form N-PORT+$8.8m−$9.8m−$991k
Dec 2025 SEC Form N-PORT+$8.0m−$4.9m+$3.1m
Nov 2025 SEC Form N-PORT+$6.9m−$3.8m+$3.1m
Oct 2025 SEC Form N-PORT+$4.6m−$3.7m+$938k
Sep 2025 SEC Form N-PORT+$5.9m−$5.3m+$575k
Aug 2025 SEC Form N-PORT+$3.8m−$3.5m+$250k
Jul 2025 SEC Form N-PORT+$3.7m−$2.0m+$1.7m
Jun 2025 SEC Form N-PORT+$6.2m−$6.2m+$34k
May 2025 SEC Form N-PORT+$1.6m−$1.6m+$44k
Apr 2025 SEC Form N-PORT+$622k$0+$622k
Mar 2025 SEC Form N-PORT+$4.4m−$2.8m+$1.7m
Feb 2025 SEC Form N-PORT+$4.1m−$3.6m+$433k
Jan 2025 SEC Form N-PORT+$4.3m−$3.3m+$972k
Dec 2024 SEC Form N-PORT+$2.1m−$2.1m+$12k
Nov 2024 SEC Form N-PORT+$4.9m−$2.9m+$2.0m
Oct 2024 SEC Form N-PORT$0$0$0

Most recent first.

How this is computed

N-PORT months: money in is sales plus reinvestments; money out is redemptions.

N-PORT months are the filed sales plus reinvestments less redemptions. Later months add up the daily data; the Source column names any missing day.

Source: ETFIQ, from the fund’s SEC N-PORT filings. Data as of Aug 31, 2026. Updated when the fund files its next report.

LFSC key stats

52-week high, daily closes to Nov 4, 2026 (ETFIQ)$48.44 on Aug 19, 2026
52-week low, daily closes to Nov 4, 2026 (ETFIQ)$31.32 on Nov 6, 2025
Close on Nov 4, 2026, within that range (ETFIQ)$45.66, 84% of the way from the low to the high
Holdings38
Top ten holdings weight54.0%
Range, beta and R-squared computed by ETFIQ from Tiingo daily prices.

Trading

as of Nov 4, 2026
Trading · LFSCas of Nov 4, 2026
·
Not scored1 of 6 measured · Nov 4, 2026
0 · Hard to tradeIQ Liquidity Score100 · Trades like a giant
Cost for your order · one way, half its 30-day median spread
How to tradeSpread not read.
Full trading page: components, premium history, dealers →

LFSC for holders outside the US

US tax withheld on dividends, no treaty30%
Treaty rates on dividends (IRS table, read Oct 30, 2026)65 countries, 10% to 30%
LFSC interest-related and short-term gain dividendsnot read by ETFIQ
US estate tax filing threshold, non-resident holders$60,000
Share classDistributing

LFSC is a US fund. Stock of US corporations counts as US property for a non-resident's estate. Facts from the IRS, not tax advice. How withholding and treaties work
Download all holdings

LFSC top ten by weight, 54.0% of the fund, of its 37 equity positions, from the holdings filed for Aug 31, 2026. Source: the fund’s SEC filing.

Source: Holdings filing (SEC Form N-PORT).

About LFSC

Theme (ETFIQ, editorial)Broad innovation and megatrends
First tradedOct 31, 2024
Already in the S&P 500, by weight (ETFIQ)0.0%
Outside the S&P 500, by weight (ETFIQ)100%
Active share vs the S&P 500 (ETFIQ)100.0%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
Active share vs the Nasdaq-100 (ETFIQ)100.0%
Top ten holdings weight54.0%
Holdings38
Holdings as of (SEC N-PORT)Aug 31, 2026
Top holdingsTravere Therapeutics Inc 8.7%, Corcept Therapeutics Inc 6.7%, Spyre Therapeutics Inc 6.7%, LivaNova PLC 6.6%, Cogent Biosciences Inc 6.5%, Mirum Pharmaceuticals Inc 4.3%, Billiontoone Inc 3.9%, Guardant Health Inc 3.8%, Cytokinetics Inc 3.5%, United Therapeutics Corp 3.3%
Net assets (SEC filing, whole fund, as filed for Aug 31, 2026)$126mReport
Benchmark (ETFIQ, from its filings)Russell 3000 Total Return, measured by IWV, which tracks the same index
Benchmark named inits shareholder report, N-CSRS, May 7, 2026
LFSC, 1 year to Nov 4, 2026+43.6%
IWV, the same days+14.8%
Against its benchmark, 1 year (ETFIQ)+28.8 pts
Below its all-time high (ETFIQ)−5.7%
Expense ratio (497 XBRL, Jan 5, 2026)0.54%Report
Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ)0.54%
Closest funds by holdings overlapXBI 15%, HELX 15%, HLTH 14%, FMED 12%, EKG 12%
Below its all-time high5.7%, high on Aug 19, 2026
How we measure
The top ten holdings are 54% of the fund across 38 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +43.6% with distributions reinvested against +14.8% for its benchmark, the Russell 3000 Total Return, so a holder was ahead by 28.8 pts. It sits 5.7% below its all-time high of Aug 19, 2026.
Holdings from the fund’s latest public SEC N-PORT filing; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. Method
IQ Investment Committee on LFSC

12 seats on LFSC, as of Nov 4, 2026: 1 Supports, 1 Mixed, 6 Challenges, 4 Not enough data.

In the tradition ofJohn BogleBogle-style Low CostChallenges
In the tradition ofBenjamin GrahamGraham-style Margin of SafetyChallenges
In the tradition ofWarren Buffett & Charlie MungerBuffett & Munger-style QualityNot enough data
In the tradition ofPeter LynchLynch-style Growth at a Reasonable PriceNot enough data
In the tradition ofJohn TempletonTempleton-style Global ContrarianNot enough data
In the tradition ofRay DalioDalio-style All-WeatherNot enough data
In the tradition ofHoward MarksMarks-style Cycles & RiskChallenges
In the tradition ofStanley DruckenmillerDruckenmiller-style Macro & LiquidityChallenges
In the tradition ofDavid SwensenSwensen-style DiversificationChallenges
In the tradition ofCathie WoodWood-style Disruptive InnovationChallenges
In the tradition ofJesse LivermoreLivermore-style Trend FollowingSupports
Uses ETFIQ’s measuresThe ETFIQ SkepticETFIQ’s own seatMixed
Put LFSC to the committee →See all seats →No investor named is affiliated with or endorses ETFIQ. Not investment advice.

Questions people ask about LFSC

How much of LFSC is in S&P 500 companies?
By its holdings filed for Aug 31, 2026, 0% of LFSC by weight is stocks the S&P 500 already holds. Its active share against the index is 100%, so that share is the part doing something different.
What does LFSC hold?
38 positions as filed for Aug 31, 2026, with the top ten at 54% of the fund. The largest are Travere Therapeutics Inc at 8.7%, Corcept Therapeutics Inc at 6.7%, Spyre Therapeutics Inc at 6.7%.
Has LFSC beaten the S&P 500?
Over the year to Nov 4, 2026 LFSC returned +43.6% with distributions reinvested, against +14.8% for the S&P 500, so it finished ahead of the index by 28.8 points.
What does LFSC cost?
The prospectus expense ratio is 0.54% a year. Because 100% of the fund differs from the S&P 500, the fee on that differing part works out at 0.54%.
Sources and dates
Prices, LFSC, Benchmark (IWV) and S&P 500 (SPY)Tiingo end-of-day · Nov 4, 2026
Net assets, $126mSEC filing, whole fund · Aug 31, 2026

Links are sources, not endorsements.

Cite this pageCitation, APA and Markdown

ETFIQ, LFSC, thematic ETFs, data as of Nov 4, 2026. https://etfiq.com/funds/lfsc

The difference bar for LFSC, redrawn every trading night.

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

How differently the money is placed, counting weights: one minus the sum of the smaller weight of each security across the fund and the index. 100% means nothing in common; 0% means the index itself. Two funds can hold the same names and still have a high active share if they weight them very differently.
Weight overlap
The share of money two portfolios hold in the same securities at the same weight.
Already in the index
The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at different weights.
The weight of the ten largest holdings. Above 50% the fund is a bet on a handful of companies, whatever the theme.
Embed this chart

Free to use with the credit link. Paste this where the chart should go; it updates every trading night.

LFSC: 0% of LFSC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026.
<figure style="margin:0;max-width:640px">
<iframe src="https://etfiq.com/embed/themes/lfsc/" title="LFSC: 0% of LFSC&#x27;s weight is in S&amp;P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026." width="640" height="346" loading="lazy" style="border:0;max-width:100%;width:100%"></iframe>
<figcaption style="font:13px/1.5 sans-serif">LFSC: 0% of LFSC&#x27;s weight is in S&amp;P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026. Data: <a href="https://etfiq.com/funds/lfsc">ETFIQ</a></figcaption>
</figure>

How to embed ETFIQ charts

Get the ETFIQ Daily

The day's ETF flows, a comparison and one number. Every trading morning. About the Daily

The ETFIQ Daily and our other emails. Unsubscribe from any one in a click. See Privacy.

Snapshot, Nov 4, 2026. More on the tabs above.